Investment analysts at StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Free Report) in a report issued on Wednesday. The brokerage set a “sell” rating on the stock. Separately, LADENBURG THALM/SH SH reissued a “neutral” rating on shares of Ayala Pharmaceuticals in a research note on Thursday, November 16th. Read Our Latest […]
StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report released on Tuesday. The firm issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH reaffirmed a neutral rating on shares of Ayala Pharmaceuticals in a research report on Thursday, November 16th. Get Our Latest Stock Analysis on […]
StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report released on Tuesday. The brokerage issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH reiterated a neutral rating on shares of Ayala Pharmaceuticals in a research note on Thursday, November 16th. View Our Latest Analysis on Ayala […]
StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a report published on Sunday. The firm issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH reaffirmed a neutral rating on shares of Ayala Pharmaceuticals in a research note on Thursday, November 16th. View Our Latest Research Report on ADXS […]
StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note released on Sunday morning. The brokerage issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH reissued a neutral rating on shares of Ayala Pharmaceuticals in a report on Thursday, November 16th. View Our Latest Analysis on Ayala […]